Rolph Timothy, the Chief Scientific Officer of Akero Therapeutics Inc . (NASDAQ:AKRO), recently executed a notable share sale ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
5don MSN
Just one month into 2025, a handful of stocks have already generated some massive gains. Top 2025 performers include several ...
We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we are going to take a look at ...
What especially shook investors was the prospect that China may have closed the tech gap with the United States in AI and especially DeepSeek’s claim that it developed R1 for just $5.6 million—a far ...
Though things are looking up for Akero, the stock still looks risky. Akero Therapeutics is developing efruxifermin as a ...
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback